Treatments for Peyronie’s disease (PD) include surgical management and collagenase clostridium histolyticum (CCH).
To evaluate PD treatment trends after CCH approval and compare clinical outcomes in CCH- and surgery-treated cohorts.
Treatments for Peyronie’s disease (PD) include surgical management and collagenase clostridium histolyticum (CCH).
To evaluate PD treatment trends after CCH approval and compare clinical outcomes in CCH- and surgery-treated cohorts.